Advertise

Using 340B Employed to advertise is a great way to get your product or service in front of 340B professionals and others in the healthcare industry. For more information about advertising, please contact Rob Miller at rob.miller@340bhealth.org or (202) 552-5857.

340B Health Members and Corporate Partners receive a 50% discount.

Rates and Specifications

Size (pixels)	1 Month	3 Months	6 Months	12 Months
Headers (60 h x 460 w)	$260	$625	$1150	$2150
Footers (60 h x 460 w)	$260	$625	$1150	$2150
Skyscraper (500 h x 120 w)	$260	$625	$1150	$2150

Submit as TIF or JPG (static) or GIF (animated) with a minimum resolution of 72 dpi.

340B Health and Other Groups Sue HHS Challenging Delay of 340B Regulation
Print ArticleSeptember 11, 2018—Today, 340B Health and three other national hospital associations have filed suit to force the U.S. Department of Health and Human Services (HHS) to enforce rules prohibiting manufacturers from overcharging 340B providers. The suit also would compel HHS to post 340B ceiling prices on a secure website. In 2010, Congress responded to […]
Writing in The New York Times, Economist Ignores Research Showing 340B Is Working
Print Article September 7, 2018—Healthcare economist Austin Frakt recently wrote in The New York Times that the 340B drug discount program includes hospitals “that don’t need the extra help” and don’t use the program to benefit low-income patients. That’s a one-sided view that ignores research showing 340B is working as Congress intended. The research Frakt […]
Faces of 340B: Lifesaving Care During Disasters
Print ArticleAugust 23, 2018—Hurricane Harvey made landfall in Texas just over a year ago, dumping more than 40 inches of rain in the Houston metropolitan area. More than 30,000 people were displaced in the resulting floods. It also created a public health crisis that demanded a rapid response. The Centers for Disease Control and Prevention […]
New Independent Study Confirms 340B is a Small Share of U.S. Drug Market
Print ArticleAugust 8, 2018—A new report by independent researchers refutes claims by the pharmaceutical industry that the 340B drug pricing program is so large it forces manufacturers to raise their prices. Writing in the Health Affairs Blog, a team of researchers from the Pew Charitable Trusts found the 340B program is only 1.4 percent of […]
New Study on Cancer Care Has Important Implications for 340B
Print ArticleAugust 7, 2018—Critics of the 340B drug pricing program often claim that the lower cost of drugs for 340B hospitals is driving up the cost of care for cancer patients in hospital outpatient departments. But a new study published in the American Journal of Managed Care (AJMC) shows cancer care spending is actually lower […]

340bemployed.org

Your Free Source for 340B News and Commentary

Advertise